Hsbc Holdings PLC Pacira Bio Sciences, Inc. Transaction History

Hsbc Holdings PLC

$168 Billion
Q3 2024

A detailed history of Hsbc Holdings PLC transactions in Pacira Bio Sciences, Inc. stock. As of the latest transaction made, Hsbc Holdings PLC holds 15,229 shares of PCRX stock, worth $314,326. This represents 0.0% of its overall portfolio holdings.

Number of Shares

15,229

Previous 28,733 47.0%

Holding current value

$314,326

Previous $822,000 72.14%

% of portfolio

0.0%

Previous 0.0%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$11.7 - $28.46 $157,996 - $384,323	-13,504 Reduced 47.0%	15,229 $229,000
Q2 2024 Aug 12, 2024	BUY	$25.5 - $31.51 $313,012 - $386,785	12,275 Added 74.58%	28,733 $822,000
Q1 2024 May 15, 2024	BUY	$27.7 - $35.48 $151,740 - $194,359	5,478 Added 49.89%	16,458 $480,000
Q4 2023 Feb 12, 2024	BUY	$26.32 - $34.31 $29,320 - $38,221	1,114 Added 11.29%	10,980 $370,000
Q3 2023 Nov 13, 2023	BUY	$30.68 - $40.09 $87,315 - $114,096	2,846 Added 40.54%	9,866 $302,000
Q2 2023 Aug 11, 2023	SELL	$36.12 - $47.5 $279,171 - $367,127	-7,729 Reduced 52.4%	7,020 $281,000
Q1 2023 May 15, 2023	BUY	$35.53 - $43.38 $186,887 - $228,178	5,260 Added 55.43%	14,749 $601,000
Q4 2022 Feb 14, 2023	BUY	$38.19 - $57.45 $56,292 - $84,681	1,474 Added 18.39%	9,489 $366,000
Q3 2022 Nov 14, 2022	BUY	$51.24 - $58.89 $157,511 - $181,027	3,074 Added 62.21%	8,015 $434,000
Q2 2022 Aug 11, 2022	SELL	$51.49 - $81.64 $238,141 - $377,585	-4,625 Reduced 48.35%	4,941 $289,000
Q1 2022 May 16, 2022	BUY	$60.03 - $76.49 $574,246 - $731,703	9,566 New	9,566 $730,000
Q1 2021 May 14, 2021	SELL	$59.31 - $78.82 $1.2 Million - $1.6 Million	-20,260 Closed	0 $0
Q4 2020 Feb 12, 2021	BUY	$50.47 - $66.26 $181,591 - $238,403	3,598 Added 21.59%	20,260 $1.21 Million
Q3 2020 Nov 12, 2020	BUY	$51.97 - $63.0 $865,924 - $1.05 Million	16,662 New	16,662 $1.01 Million
Q2 2020 Aug 14, 2020	SELL	$30.8 - $52.47 $189,019 - $322,008	-6,137 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$28.4 - $50.7 $174,290 - $311,145	6,137 New	6,137 $206,000
Q4 2019 Feb 14, 2020	SELL	$36.31 - $46.83 $1.27 Million - $1.63 Million	-34,872 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$35.66 - $44.99 $1.24 Million - $1.57 Million	34,872 New	34,872 $1.33 Million
Q4 2018 Feb 13, 2019	SELL	$41.31 - $52.16 $2.17 Million - $2.74 Million	-52,471 Closed	0 $0
Q3 2018 Nov 13, 2018	BUY	$32.85 - $52.0 $1.72 Million - $2.73 Million	52,471 New	52,471 $2.57 Million

Others Institutions Holding PCRX

# of Institutions

263

Shares Held

50.4M

Call Options Held

429K

Put Options Held

391K

View Full List

About Pacira BioSciences, Inc.

Ticker PCRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 45,824,200
Market Cap $946M
Description
Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid ...

More about PCRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Hsbc Holdings PLC, based on Form 13F filings with the SEC.

News

Stay updated on Hsbc Holdings PLC with notifications on news.

Account

Hsbc Holdings PLC Pacira Bio Sciences, Inc. Transaction History